COMMENSAL GUT-DERIVED ANAEROBES AS NOVEL THERAPY FOR INFLAMMATORY AUTOIMMUNE DISEASES

Medicine & Life Sciences

1. Adaptive Immunity 11%
2. Anaerobic Bacteria 13%
3. Animal Disease Models 14%
4. Animal Models 15%
5. Anti-Inflammatory Agents 20%
6. Arthritis 14%
7. Autoimmune Diseases 100%
8. Autoimmune Experimental Encephalomyelitis 38%
9. B-Lymphocytes 16%
10. Bacteria 59%
11. Bifidobacterium 6%
12. Cell- and Tissue-Based Therapy 10%
13. Chemokines 10%
14. Crohn Disease 5%
15. Cytokines 20%
16. Developed Countries 15%
17. Epigenomics 9%
18. Experimental Arthritis 39%
19. Gastrointestinal Microbiome 16%
20. Genes 8%
21. Genetic Background 5%
22. Gram-Negative Bacteria 11%
23. Habits 5%
24. Health 5%
25. Histocompatibility Antigens 6%
26. Histocompatibility Antigens Class II 12%
27. HLA Antigens 11%
28. HLA-DR2 Antigen 17%
29. HLA-DR3 Antigen 16%
30. HLA-DR4 Antigen 16%
31. Hygiene 5%
32. Hygiene Hypothesis 17%
33. Immune System 17%
34. Immune Tolerance 13%
35. Immunization 18%
36. Immunosuppressive Agents 9%
37. Incidence 8%
38. Innate Immunity 10%
39. MHC Class II Genes 22%
40. Mouse Plp1 protein 23%
41. Mucosal Immunity 13%
42. Multiple Sclerosis 92%
43. Pathology 6%
44. Preliminary Data 11%
45. Prevotella 38%
46. Probiotics 46%
47. Regulatory T-Lymphocytes 32%
48. Rheumatoid Arthritis 86%
49. Sanitation 13%
50. T-Lymphocytes 6%
51. Therapeutics 18%
52. To autoantigen 8%
53. Transgenic Mice 14%